Please sign in to follow a disease.

Refractory follicular lymphoma grade 3B

Clinical trials for Refractory follicular lymphoma grade 3B explained in plain language.

Never miss a new study

Get alerted when new Refractory follicular lymphoma grade 3B trials appear

Sign up with your email to follow new studies for Refractory follicular lymphoma grade 3B, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Can a Faster-Dosed antibody drug paired with lenalidomide help lymphoma that came back after CAR T-Cell therapy?

Disease control Not yet recruiting

Researchers are testing a combination of two drugs, epcoritamab and lenalidomide, in adults whose large B-cell lymphoma has come back after CAR T-cell therapy. The trial enrolls about 55 people in France. Participants receive epcoritamab as a shot under the skin using a faster do…

Matched conditions: REFRACTORY FOLLICULAR LYMPHOMA GRADE 3B

Phase 2 • Sponsor: The Lymphoma Academic Research Organisation • Aim: Disease control

Last updated Sep 12, 2026 00:00 UTC

Refractory follicular lymphoma grade 3B

Get alerted when new Refractory follicular lymphoma grade 3B trials appear

Can a Faster-Dosed antibody drug paired with lenalidomide help lymphoma that came back after CAR T-Cell therapy?